Hedeker Wealth’s Novo Nordisk NVO Stock Holding History

Hedeker Wealth’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-28,440	Closed	-$759K	–	161
2015 Q1	$759K	Hold	28,440	–	–	0.63%	47
2014 Q4	$602K	Buy	+28,440	New	+$635K	0.49%	54

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hedeker Wealth's NVO Position: Q2 2015 in Review

Hedeker Wealth sold out of Novo Nordisk (NVO) in Q2 2015, closing a stake of 28,440 shares — an estimated $759K sold.

Hedeker Wealth first reported a position in NVO in Q4 2014 and held it in 2 quarters. The position peaked at $759K in Q1 2015. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2015.

Hedeker Wealth reported no remaining Novo Nordisk position as of Q2 2015 after selling out during the quarter.
Hedeker Wealth sold 28,440 Novo Nordisk shares in Q2 2015, an estimated $759K.
Hedeker Wealth first reported a position in Novo Nordisk in Q4 2014 and held it in 2 quarters.
Hedeker Wealth's Novo Nordisk position peaked at $759K in Q1 2015.
516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2015.

Based on Hedeker Wealth's 13F filing for Q2 2015, filed 11 Aug 2015.